Barclays analyst Andrew Mok raised the firm’s price target on UnitedHealth (UNH) to $655 from $603 and keeps an Overweight rating on the shares as part of an investor day preview. The firm expects a 2025 medial loss ratio of 85.9% and nearly 100 basis points of cost savings to arrive at an initial 2025 earnings per share outlook of $29.50-$30.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- RBC sees little cause for concern over CMS’ proposed part D GLP-1 coverage rule
- UnitedHealth Investor Conference to Discuss 2025 Growth
- UnitedHealth price target raised to $655 from $595 at RBC Capital
- Trump Weekly: Trump looks to drop EV tax credit, fuel-efficiency requirements
- Trump Trade: Transition team weighing White House crypto role